Migraine drug is first to tackle debilitating early symptoms

Nature, Published online: 12 May 2025; doi:10.1038/d41586-025-01503-3

Results from a phase III clinical trial suggest that taking ubrogepant at the first sign of an oncoming migraine can prevent pre-headache fatigue and light sensitivity.